This expands eureKARE’s synthetic biology studio network – each with a different theme – in Europe’s innovation hotspots. The Monaco studio will be the network’s hub for climate change-focused innovation.
When it comes to innovation in synthetic biology (or “SynBio”), we’re seeing Europe punch above its weight but there remains a disconnect in seeing this translate into commercial value and investment, falling behind other major players, namely the US.
In his introductory speech, His Serene Highness Prince Albert II of Monaco stated: “I am especially pleased that the Principality of Monaco is able to welcome your work, support it and contribute to its success. I also welcome the dialogue that has been established between eureKARE and the Scientific Center of Monaco, in particular the opportunity to host one of your studios on its premises, like those you have already set up in various scientific centers across Europe”.
Organized by eureKARE and the Centre Scientifique de Monaco (CMS), SynBio Day, a conference about synthetic biology, took place in mid-October in the Principality of Monaco, giving an opportunity to discuss advances in technologies with tremendous potential.